Safety Data Review Across published studies, CJC-1295 has demonstrated a favorable safety profile: Common Adverse Events Injection site reactions (redness, swelling, pain): the most frequently reported side effect Headache: mild and transient Diarrhea: reported in some subjects, particularly at higher doses Flushing: transient warmth or redness Dizziness: occasional and brief Serious Adverse Events One serious adverse event in the early clinical development program, a death that occurred in a subject during a study, drew attention
While these effects initially made GLP-1 seem a promising candidate for drug development, the earliest clinical studies from 1992 and 1993 revealed that GLP-1s half-life in the body was disappointingly short
coli strain BL21 (DE3) or strain XL1-Blue and purified by Ni-NTA affinity chromatography as described previously 14,26,35,88
Exclusion criteria involved non-peer-reviewed sources, articles lacking primary data or mechanistic insights, and studies unrelated to GI health
Cch dng hiu qu S dng ng ung
